NCT03521232View on ClinicalTrials.gov

A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

September 19, 2022

Study Completion Date

October 4, 2022

Conditions
Ulcerative ColitisUlcerative ProctitisUlcerative Proctosigmoiditis
Interventions
DRUG

Niclosamide

enema given twice daily for 6 weeks

Trial Locations (1)

Unknown

Tor Vegata, Rome

Sponsors
All Listed Sponsors
lead

Entero Therapeutics

INDUSTRY